Not available
Quote | Accelerate Diagnostics Inc. (NASDAQ:AXDX)
Last: | $0.77 |
---|---|
Change Percent: | 0.88% |
Open: | $0.73 |
Close: | $0.77 |
High: | $0.7971 |
Low: | $0.73 |
Volume: | 34,997 |
Last Trade Date Time: | 04/18/2024 03:00:00 am |
News | Accelerate Diagnostics Inc. (NASDAQ:AXDX)
2024-03-28 19:50:04 ET Accelerate Diagnostics Inc. (AXDX) Q4 2023 Results Conference Call March 28, 2024 4:30 PM ET Company Participants Laura Pierson - Investor Relations Officer Jack Phillips - CEO, President and Director David Patience - CFO, Principal Financi...
2024-03-28 16:16:23 ET More on Accelerate Diagnostics Accelerate Diagnostics prices $15M public offering and private placement, shares fall Accelerate Diagnostics announces launch of proposed public offering Seeking Alpha’s Quant Rating on Accelerate Diagnosti...
Message Board Posts | Accelerate Diagnostics Inc. (NASDAQ:AXDX)
Subject | By | Source | When |
---|---|---|---|
$AXDX MomentumIts now last trade up | lodoguy | investorshub | 07/09/2023 5:28:46 PM |
got some short data | lodoguy | investorshub | 07/06/2023 8:54:44 PM |
What do you make of this? | mmillionaire | investorshub | 07/06/2023 7:29:49 PM |
$AXDX The gaining | mmillionaire | investorshub | 06/30/2023 10:18:51 AM |
oh yeah news for the day | FairviewInvestor | investorshub | 06/29/2023 11:32:47 AM |
News, Short Squeeze, Breakout and More Instantly...
Accelerate Diagnostics Inc. Company Name:
AXDX Stock Symbol:
NASDAQ Market:
Accelerate Diagnostics Inc. Website:
Accelerate Diagnostics Reports Fourth Quarter and Full-Year 2023 Financial Results PR Newswire TUCSON, Ariz. , March 28, 2024 /PRNewswire/ -- Accelerate Diagnostics, Inc. (Nasdaq: AXDX) today announced financial results for the fourth quarter and year ended ...
Swire Pacific Ltd. ADR (Class A) (SWRAY) is expected to report for Q4 2023 Troika Media Group Inc. (TRKAQ) is expected to report for quarter end 2023-12-31 American Environmental Partners Inc. (AEPT) is expected to report for quarter end 2023-12-31 Veolia Environnement S.A. ADR (VEOEY...
Accelerate Diagnostics Scheduled Call to Review 2023 Fourth Quarter and Full Year Results. PR Newswire TUCSON, Ariz. , March 7, 2024 /PRNewswire/ -- Accelerate Diagnostics, Inc. (NASDAQ: AXDX) announced today that management will host a conference call on Thurs...